The novel mineralocorticoid receptor antagonist finerenone attenuates neointima formation after vascular injury.
Model: Electric denudation injury of the left common carotid artery (2 W for 2 seconds per millimetre over 4 mm) and wire-induced dilation injury of the femoral artery (0.38 mm straight spring wire advanced 1 cm and left in place for 1 minute)
Finerenone at 10 nM prevented aldosterone-induced smooth muscle cell proliferation and at 1 nM prevented endothelial cell apoptosis in vitro. In vivo, re-endothelialisation at day 3 increased from 0.52 plus or minus 0.12 mm with vehicle to 1.13 plus or minus 0.16 mm at 1 mg/kg/day and 1.083 plus or…
Extraction: extract · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.